Centessa Pharmaceuticals Revenue

In the year 2025, Centessa Pharmaceuticals had annual revenue of $15.00M.

Revenue (ttm)

$15.00M

Revenue Growth

n/a

P/S Ratio

406.86

Revenue / Employee

$127,119

Employees

118

Market Cap

6.10B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	15.00M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	6.85M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CNTA News

4 weeks ago - Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewsWire
4 weeks ago - Eli Lilly stock rises after $7.8B Centessa deal—bet on sleep drugs - Invezz
4 weeks ago - Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs - CNBC
4 weeks ago - Eli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion - WSJ
4 weeks ago - Eli Lilly to buy Centessa Pharma in $6.3 billion deal - Reuters
4 weeks ago - Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PRNewsWire
7 weeks ago - Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire
2 months ago - Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals - GlobeNewsWire

More News